Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
REVENUES $ 726 $ 1,848
COST OF REVENUES 506 1,160
GROSS PROFIT 220 688
OPERATING EXPENSES:    
Research and development expenses 647 757
Sales and marketing expenses, net 627 929
General and administrative expenses 817 865
TOTAL OPERATING EXPENSES 2,091 2,551
OPERATING LOSS (1,871) (1,863)
Interest expenses (207) (180)
Other Financial income, net 92 148
Net loss for the period $ (1,986) $ (1,895)
Net loss per share attributable to common shareholders – basic (in Dollars per share) $ (0.5) $ (1.09)
Weighted average number of common stock used in computing net loss per share – basic (in Shares) 3,978,828 1,734,160